Jean-Ehrland Ricci
@jer_06200
Followers
1K
Following
4K
Media
46
Statuses
2K
Inserm research director & metabolism-lover, studying metabolism in cancer & immunity. Editor-in-Chief of Oncogenesis https://t.co/ungSzEHJya
Nice, France
Joined April 2012
0
3
0
RT @Oncogenesis_: Check how the authors used intestinal organoids with colorectal cancer (CRC) driver mutations as model system to investig….
0
1
0
RT @Oncogenesis_: “TGF-β signaling redirects Sox11 gene regulatory activity to promote partial EMT and collective invasion of oncogenically….
0
1
0
Early methionine availability attenuates T cell exhaustion | Nature Immunology
nature.com
Nature Immunology - The tumor environment is nutrient deficient. Here the authors show that early availability of methionine is critical for optimal T cell activation and prevents...
0
0
1
RT @Oncogenesis_: Check how Multi-Omics Factor Analysis (MOFA+) was employed to integrate transcriptomic, proteomic, and metabolomic data o….
0
1
0
RT @Oncogenesis_: “Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes”. Guro F. Giskeødegår….
0
1
0
RT @Oncogenesis_: Check the biochemical and bioinformatic criteria that the authors use to distinguish functional miRNAs from mistakenly an….
0
1
0
RT @Oncogenesis_: The reason behind this title? . Numerous “miRNAs” previously reported in EMT and cancer contexts, are not incorporated….
0
1
0
RT @Oncogenesis_: “Chasing non-existent “microRNAs” in cancer”. ⚠️The recent publication by Katherine Pillman, Greg Goodall and Cameron P.….
0
1
0
RT @Oncogenesis_: 💊 Check how the authors proposed effective drug combinations for AML patients with the highest efficacy and lowest toxici….
0
1
0
RT @Oncogenesis_: Groundbreaking research led by @MohieddinJafari has been featured in #Oncogenesis. “Designing patient-oriented combinat….
0
1
0
New study extends our work on protein restriction and anticancer immunity Here, protein restriction also enhances chemo efficacy (5-FU) and immune infiltration. Diet as an immunometabolic adjuvant is gaining ground.
0
1
4
RT @Chrest_brett: Excellent article by DeBerardinis: "trust your instincts, capitalize on your environment, ask challenging questions, thin….
nature.com
Nature Cancer - Ralph DeBerardinis obtained an MD and PhD from the University of Pennsylvania, then trained in Pediatrics and Medical Genetics at Children’s Hospital of Philadelphia. He moved...
0
7
0
RT @Oncogenesis_: That’s why he recently accepted the role of Editor-in-Chief of Oncogenesis — a journal that researchers can trust. Let’s….
0
1
0
RT @Oncogenesis_: One of his growing concerns is the rise of predatory journals, which lure researchers with quick publication promises but….
0
1
0
RT @Oncogenesis_: Over the years, he has also served on multiple national and international scientific advisory boards and editorial commit….
0
1
0
RT @Oncogenesis_: Meet Editor-in-Chief, Jean-Ehrland Ricci @jer_06200. As Research Director at Inserm and head of the “metabolism, CAncer a….
0
2
0
Small-molecule OPA1 inhibitors disrupt mitochondrial cristae, amplify cytochrome c release & restore apoptosis in Bcl-2–inhibitor–resistant cancer cells. Targeting OPA1 could re-sensitize stubborn tumors to therapy | Science Advances @LabScorrano.
science.org
OPA1 inhibitors from large-scale screening and chemical optimization restore cancer cell sensitivity to apoptosis-inducing drugs.
0
0
4
RT @LabScorrano: Kudos to @AnnaPellattiero C Quirin @MagrinFederico, great collaborators S Moro A Mattarei @msturlese @ProfGavathiotis for….
science.org
OPA1 inhibitors from large-scale screening and chemical optimization restore cancer cell sensitivity to apoptosis-inducing drugs.
0
12
0
RT @ERC_Research: 📣 Ever considered applying for a ERC Starting Grant? The 2026 Call for proposals is now open!. Application portal 👉 https….
0
38
0